Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24-Week Randomized, Placebo-Controlled, Multicenter Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24-Week Randomized, Placebo-Controlled, Multicenter Trial

Published:2011-09 Issue:9 Volume:19 Page:1796-1803
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:

Author:

Smith Steven R.,Stenlof Kaj S.,Greenway Frank L.,McHutchison John,Schwartz Susan M.,Dev Vidhu B.,Berk Evan S.,Kapikian Roxanne

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/oby.2011.143/fullpdf

Reference33 articles.

1. Abdominal obesity and metabolic syndrome;Després;Nature,2006

2. Influence of body fat content and distribution on variation in metabolic risk;Vega;J Clin Endocrinol Metab,2006

3. Role of body fat distribution and the metabolic complications of obesity;Jensen;J Clin Endocrinol Metab,2008

4. Visceral fat is an independent predictor of all-cause mortality in men;Kuk;Obesity (Silver Spring),2006

5. Independent associations between liver fat, visceral adipose tissue, and metabolic risk factors in men;McMillan;Appl Physiol Nutr Metab,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to review by Pan et al.;Obesity;2024-07-10

2. Do anti-obesity medical treatments have a direct effect on adipose tissue?;Annales d'Endocrinologie;2024-06

3. Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks;Alimentary Pharmacology & Therapeutics;2024-01-02

4. Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review;Medicine;2023-09-08

5. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options;Frontiers in Cardiovascular Medicine;2023-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3